# Cinsano Pharma, Inc. — Form D

Cinsano Pharma, Inc. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-06. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Other.

## Offering

- Filed: 2024-06-06
- Form: D
- Accession: 0002026076-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 1
- Date of first sale: 2024-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515287

## Issuer

- Name: Cinsano Pharma, Inc.
- CIK: 0002026076
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 5375 MEDPACE WAY, CINCINNATI, OH, 45227
- Phone: 513.579.9911

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Jonathan Isaacsohn | Director | Cincinnati, OH |
| Jonathan Isaacsohn | Executive Officer | Cincinnati, OH |

## More

- [CIK 2026076 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2026076&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002026076-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.